ClinConnect ClinConnect Logo
Search / Trial NCT06588647

Improving Participation After Stroke Self-Management-Rehabilitation

Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Sep 6, 2024

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

Stroke Self Management Telehealth Activities Of Daily Living Community Engagement

ClinConnect Summary

This clinical trial is looking at a new program designed to help people who have had a mild or moderate stroke manage their recovery better. The focus is on teaching participants skills to boost their confidence, improve their daily activities, and enhance their overall quality of life, all through small group sessions conducted online. This means that participants can join from home, making it easier to stay engaged in their recovery process.

To be part of this study, participants should be between 45 and 85 years old, have had a stroke less than six months ago, and have finished any recommended rehabilitation in a hospital. They also need to be able to understand and communicate in English and use video conferencing tools, either on their own or with help. The trial is currently recruiting participants, and it aims to provide valuable support for those recovering from stroke while ensuring that everyone involved can safely participate in the program.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • less than 6 months post-stroke
  • age 45-85 years
  • completed inpatient rehabilitation services (if recommended)
  • living in the community with or without caregiver support (i.e., not living in a skilled nursing facility)
  • ability to read, write, and speak English
  • diagnosis of mild or moderate stroke (National Institutes of Health stroke score \<16)
  • able to use videoconferencing independently or with caregiver support
  • Exclusion Criteria:
  • severe depressive symptoms as indicated by a score ≥21 on the Patient Health Questionnaire
  • dementia symptoms as indicated by a score of \<23 on the Montreal Cognitive Assessment
  • additional neurological diagnoses (e.g., brain malignancy, previous severe stroke)
  • (4) moderate or severe aphasia as indicated by a National Institutes of Health Stroke Scale aphasia score of ≥ 2
  • inability to provide informed consent
  • any other condition not otherwise specified that the PI determines would render participation in this study as unsafe for the participant

About University Of Missouri Columbia

The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.

Locations

Columbia, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Anna E Boone, PhD, OTR/L

Principal Investigator

University of Missouri Occupational Therapy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported